MarginsXMarginsX
Home › Markets › Health Care › NRXS

Neuraxis Inc. (NRXS)

NRXS trades on NYSE in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$4.80
-11.44% on the day
Market cap
$68.1M
Micro cap
Revenue · 2025
$3.6M
+32.9% on 2024
Net income · 2025
-$7.8M
-218.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1933567/000149315226011505/0001493152-26-011505-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerNRXS on NYSE
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO year2023
SEC CIK0001933567
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$3.6M
Net income-$7.8M
Operating income-$7.8M
Net margin-218.5%
Operating margin-219.4%
Revenue growth+32.9%
Cash$5.0M
Total assets$6.4M
P/E (computed)Net income was not positive
P/S (computed)19.1×

Warning signs

Cash runway
8.3 months
$4.5M cash at September 30, 2026
Share count, 1 year
+33.2%
2025-11-07 to 2026-11-06 · +168.3% over 3 years
Going-concern doubt
Yes
10-Q filed November 9, 2026
Insider net buying, 12 months
$1.4M
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As a result, substantial doubt is deemed to exist about the Company's ability to continue as a going concern."
10-Q 2026-11-09
Cash and burn$4.5M cash; operating cash flow -$1.6M a quarter.Report 2026-09-30
Shares outstanding14,193,209 (2026-11-06); 10,652,812 a year earlier; 5,289,514 three years earlier.Cover page 2026-11-06
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-04-21
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorRosenberg Rich Baker Berman, P.A., Somerset, New Jersey, United StatesPCAOB Form AP 2026-04-07
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $1.4M, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$2.0M-$6.5M-$2.3M$4.5M$415K$6.5M10-Q 2026-11-09
Q2 2026
2026-06-30
$1.9M-$2.1M-$1.0M$8.3M$85K$5.3M10-Q 2026-08-11
Q1 2026
2026-03-31
$1.6M-$1.8M-$1.2M$7.1M$201K$4.3M10-Q 2026-05-12
Q4 2025
2025-12-31
$968K-$1.7M-$1.9M$5.0M$297K$3.6M10-K 2026-03-19
Q3 2025
2025-09-30
$811K-$2.1M-$1.4M$4.4M$196K$3.4M10-Q 2026-11-09
Q2 2025
2025-06-30
$894K-$1.7M-$1.5M$6.0M$121K$3.2M10-Q 2026-08-11
Q1 2025
2025-03-31
$896K-$2.3M-$1.6M$2.0M$84K$2.9M10-Q 2026-05-12
Q4 2024
2024-12-31
$761K-$1.4M-$1.8M$3.7M$308K$2.7M10-K 2026-03-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-08-06
Latest annual report10-K2026-03-19
Latest quarterly / interim10-Q2026-11-09
Latest current report8-K2026-10-14
Latest proxyDEFA14A2026-04-28

Source: SEC EDGAR submissions feed, 196 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-13.1%
1 month-16.6%
3 months-13.7%
Year to date+19.4%
1 year+130.6%
From 52-week high-38.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
HYPRHyperfine Inc.$0.6101-3.05%$64.8M
OMOutset Medical Inc.$3.39-9.12%$64.0M
STXSStereotaxis Inc.$0.8027-4.80%$80.4M
POCIPrecision Optics Corporation Inc.$4.97-4.97%$54.6M
VANIVivani Medical Inc. Common Stock (DE)$1.02+0.99%$92.0M
HSDTSolana Company Class A Common Stock (DE)$1.64-5.20%$103.1M
ECORelectroCore Inc.$4.84-7.81%$44.7M
FOCLEDAP TMS S.A.$3.17-2.39%$149.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier